Carl Stuart Investment Advisor’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-836
Closed -$241K 16
2023
Q4
$241K Hold
836
0.16% 26
2023
Q3
$223K Buy
+836
New +$209K 0.18% 18
2023
Q1
Sell
-836
Closed -$220K 41
2022
Q4
$220K Buy
+836
New +$224K 0.2% 23
2022
Q3
Sell
-836
Closed -$207K 25
2022
Q2
$207K Hold
836
0.18% 25
2022
Q1
$2.02M Buy
+836
New +$192K 0.15% 26

Other funds holding AMGN

Carl Stuart Investment Advisor's AMGN Position: Q1 2024 in Review

Carl Stuart Investment Advisor sold out of Amgen (AMGN) in Q1 2024, closing a stake of 836 shares — an estimated $241K sold.

Carl Stuart Investment Advisor first reported a position in AMGN in Q1 2022 and held it in 5 quarters. The position peaked at $2.02M in Q1 2022. 2,715 funds tracked by Wall St. Rank hold AMGN as of Q1 2024.

  • Carl Stuart Investment Advisor reported no remaining Amgen position as of Q1 2024 after selling out during the quarter.
  • Carl Stuart Investment Advisor sold 836 Amgen shares in Q1 2024, an estimated $241K.
  • Carl Stuart Investment Advisor first reported a position in Amgen in Q1 2022 and held it in 5 quarters.
  • Carl Stuart Investment Advisor's Amgen position peaked at $2.02M in Q1 2022.
  • 2,715 funds tracked by Wall St. Rank held Amgen as of Q1 2024.

Based on Carl Stuart Investment Advisor's 13F filing for Q1 2024, filed 24 Apr 2024.